- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy.Renal CancerMay 24, 2022
-
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: the CABIR study.Renal CancerMay 24, 2022
-
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents.Renal CancerMay 23, 2022
-
The WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.Renal CancerMay 23, 2022
-
Impact of the Discordance Between Scales of Memorial Sloan-Kettering Cancer Center and International Metastatic Renal Cell Carcinoma Database Consortium in Patients' Prognosis With Metastatic Renal Cancer.Renal CancerMay 20, 2022
-
Glutaminase inhibition in renal cell carcinoma therapy.Renal CancerMay 20, 2022
-
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma.Renal CancerMay 19, 2022
-
Artificial Intelligence in Kidney Cancer.Renal CancerMay 19, 2022
-
Telaglenastat Plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 ENTRATA Trial.Renal CancerMay 18, 2022
-
Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.Renal CancerMay 18, 2022
Beyond the Abstracts
-
High Efficiency Capture of Biomarker miRNA15a for Noninvasive Diagnosis of Malignant Kidney Tumors - Beyond the AbstractRenal CancerMay 19, 2022
-
Immunotherapy Salvage in mRCC Pretreated with Immunotherapy - Beyond the AbstractRenal CancerMay 19, 2022
-
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors - Beyond the AbstractRenal CancerMay 11, 2022
-
Risk of Recurrence After Nephrectomy: Comparison of Predictive Ability of Validated Risk Models - Beyond the AbstractRenal CancerMay 6, 2022
-
Improving Accuracy, Reliability, and Efficiency of the RENAL Nephrometry Score with 3D Reconstructed Virtual Imaging - Beyond the AbstractRenal CancerApril 26, 2022
-
Significance of Upfront Cytoreductive Nephrectomy Stratified by IMDC Risk for Metastatic Renal Cell Carcinoma in Targeted Therapy Era – a Multi-Institutional Retrospective Study - Beyond the AbstractRenal CancerMarch 30, 2022
-
Leveraging the Heterogeneity of Adaptive Immune Cells Within the Tumor-Ecosystem to Better Describe Clear Cell Renal Cell Carcinoma Biologically and Clinically - Beyond the AbstractRenal CancerMarch 1, 2022
-
Managing the Overlapping Toxicities of Cabozantinib plus Nivolumab, a New Standard of Care in Kidney Cancer - Beyond the AbstractRenal CancerFebruary 28, 2022
-
Predictive Impact of Early Changes in Serum C-reactive Protein Levels in Nivolumab plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma - Beyond the AbstractRenal CancerFebruary 8, 2022
-
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial - Beyond the AbstractRenal CancerJanuary 28, 2022
